Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Effect of Bosentan on Healing and Prevention of Ischemic Digital Ulcers in Patients With Systemic Sclerosis

NCT00077584 is registered in ClinicalTrials.gov with Actelion as lead sponsor.

NCT NCT00077584
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00077584 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Effect of Bosentan on Healing and Prevention of Ischemic Digital Ulcers in Patients With Systemic Sclerosis
Lead sponsor
Actelion
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2003
Completion date
May 31, 2005
Enrollment
188 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

digital ulcers, systemic sclerosis